- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04047342
Assessing the Impact of myHealth Rewards New Hire Enrollment Emails
Assessing the Impact of myHealth Rewards Program-related Communications on New Hire Enrollment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Geisinger
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Any Geisinger new hire, regardless of benefits status, who started on or after July 1, 2019 and before November 30, 2019
Exclusion Criteria:
- Existing Geisinger employees hired prior to July 1, 2019
- New hires who do not have an email address on file
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Standard welcome email
The standard welcome email mentions the benefits of enrollment (maintaining good health and saving money on insurance premiums), the average premium savings, the ease of the registration process, and the deadline for registering and having health measures on file, plus it provides registration steps and hyperlinks for registering and finding free health screenings where health measures can be collected and registered at one convenient time and location.
|
Email
|
Loss frame email
The loss frame email recommends that GHP members not "throw away" a precise dollar amount in savings (over $2,000) by not participating and that they can therefore avoid missing out on substantial gains (i.e., savings) by taking action. This intervention frames the status quo as a state from which recipients, via inaction, are slated to forfeit a sizable and precise monetary amount to which they should otherwise feel entitled (via loss aversion and the endowment effect). People tend to be risk-seeking in the domain of losses; therefore, this intervention is hypothesized to increase enrollment in the hope of achieving zero loss by meeting program goals, as opposed to a sure loss via inaction. |
Email
Email
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of People Enrolled Within 7 Days
Time Frame: 7 days
|
Enrollment in the myHealth Rewards program (yes/no) within 7 full days of the beginning of the intervention for each cohort (i.e., when the emails are first sent within each weekly new hire cohort).
Data will be aggregated across cohorts, including the July 16 cohort and every subsequent cohort through the week prior to reminder emails scheduled to be sent out in October, 2019.
|
7 days
|
Number of People Who Logged in to the Program Within 7 Days
Time Frame: 7 days
|
Logging into the myHealth Rewards program (yes/no) within 7 full days of the beginning of the intervention for each cohort (i.e., when the emails are first sent within each weekly new hire cohort).
Data will be aggregated across cohorts, including the July 16 cohort and every subsequent cohort through the week prior to reminder emails scheduled to be sent out in October, 2019.
|
7 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2019-0586
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Promotion
-
National Yang Ming UniversityCompleted
-
University of New MexicoCompleted
-
Florida State UniversityCompleted
-
University of VictoriaCompleted
-
Oregon Research InstituteCompletedTobacco Smoking | Health PromotionUnited States
-
Erzi̇ncan Binali Yildirim Uni̇versi̇tesi̇Atatürk UniversityNot yet recruiting
-
Linnaeus UniversityEnrolling by invitation
-
The Institute for Functional MedicineFunctional Medicine Coaching AcademyCompleted
-
Utica CollegeCompleted
-
University of MiamiMichigan State UniversityCompleted
Clinical Trials on Welcome email
-
Centre for Addiction and Mental HealthCompleted
-
Johns Hopkins Bloomberg School of Public HealthNational Institutes of Health (NIH)Completed
-
Leanne KayeUNC Lineberger Comprehensive Cancer Center; University of North CarolinaCompletedBreast Neoplasms | Sedentary Lifestyle | Survival Rate (Survivorship)United States
-
Institute for Clinical Evaluative SciencesCanadian Institutes of Health Research (CIHR); Ontario Agency for Health Protection... and other collaboratorsCompletedAntibiotic Initiation | Antibiotic DurationCanada
-
Harvard School of Public Health (HSPH)Massachusetts General HospitalCompletedOncologyUnited States
-
Office of Evaluation SciencesCompleted
-
Vanderbilt University Medical CenterCompletedHeart Diseases | Heart FailureUnited States
-
Yale UniversityWithdrawnKnowledge Bases
-
Brigham and Women's HospitalCompletedTest Result ManagementUnited States